False-positive mammograms in women aged 40-59 years cost an estimated $2.8 billion per year in the United States in 2012-2013, according to a report p... More »
Models predicting the likelihood of a successful VBAC are as accurate for women who have undergone two previous cesarean deliveries as they are for wo... More »
SAN FRANCISCO – An investigational topical sebum inhibitor met its primary endpoints in a phase IIa trial, significantly reducing inflammatory and n... More »
SAN FRANCISCO – An investigational interleukin-23 inhibitor for moderate to severe plaque psoriasis achieved almost twice the PASI 90 response rate ... More »
A new drug candidate shows potential in laboratory studies against a rare type of acute leukemia, mixed lineage leukemia, which occurs more often in c... More »
SAN FRANCISCO – Weekly treatment with 40 mg of adalimumab yielded the strongest clinical responses in adults with moderate to severe hidradenitis su... More »
Two-thirds of endoscopists met national quality benchmarks for detecting colonic adenomas, but detection rates varied eightfold among male patients an... More »
Women with Crohn’s disease had about a 53% greater risk of developing cervical cancer compared with controls, and women with inflammatory bowel dise... More »
Women with Crohn’s disease had about a 53% greater risk of developing cervical cancer compared with controls, and women with inflammatory bowel dise... More »
Women with Crohn’s disease had about a 53% greater risk of developing cervical cancer compared with controls, and women with inflammatory bowel dise... More »